Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5998427 | WAYLIS THERAP | Androstenones |
Sep, 2013
(10 years ago) | |
US5846976 | WAYLIS THERAP | Androstenone derivative |
Sep, 2013
(10 years ago) | |
US5565467 | WAYLIS THERAP | Androstenone derivative |
Nov, 2015
(8 years ago) |
Market Authorisation Date: 20 November, 2001
Treatment: Method of inhibiting 5 alpha testosterone reductase enzyme with dutasteride or its derivative and treating androgen responsive/mediated disease including benign prostatic hyperplasia; Method of treati...
Dosage: CAPSULE;ORAL